Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Toronto Stock Exchange  >  Cardiome Pharma Corp    COM   CA14159U3010

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Engages in the discovery, development and commercialization of new therapies

Cardiome Pharma Corp. is a specialty pharmaceutical company.

It engages in the discovery, development and commercialization of cardiovascular therapies that will improve the health of patients suffering from heart disease.

Cardiome has two marketed products, BRINAVESS, approved in Europe and other territories for the rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults, and AGGRASTAT a reversible GP IIb/IIIa inhibitor indicated for use in patients with acute coronary syndrome.

The company was founded on December 12, 1986 and is headquartered in Vancouver, Canada.

Number of employees : 85 persons.
Sales per Businesses
20142015Delta
CAD (in Million)%CAD (in Million)%
Cardiovascular Therapies33.18100%26.75100% -19.37%
Sales per Regions
20142015Delta
CAD (in Million)%CAD (in Million)%
Rest of World17.3852.4%13.2349.4% -23.89%
Europe15.8047.6%13.5350.6% -14.41%
Managers
NameAgeSinceTitle
William L. Hunter, MD522007President, Chief Executive Officer & Director
William James O'Shea662014Chairman
Sheila M. Grant, MBA-2003Chief Operating Officer
Jennifer Archibald-2006Chief Financial Officer
Harold H. Shlevin, PhD662004Independent Director
Richard M. Glickman, PhD582006Lead Independent Director
Mark H. N. Corrigan, MD582015Director
Arthur H. Willms762015Independent Director
Robert James Meyer, MD-2015Director
Jürgen Polifka, PhD-2013General Manager-European Sales & Marketing
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 31,876,283 31,277,363 98.1% 0 0.0% 98.1%
Shareholders
NameEquities%
Westfield Capital Management Co. LP 5,423,142 17.0%
Putnam Investment Management LLC 3,683,481 11.6%
Tamarack Advisers LP 2,200,000 6.90%
Clough Capital Partners LP 2,044,653 6.41%
Stonepine Capital Management LLC 1,778,317 5.58%
Rock Springs Capital Management LP 1,190,000 3.73%
Fidelity Management & Research Co. 627,363 1.97%
William L. Hunter, MD 607,452 1.91%
AlphaOne Investment Services LLC 580,965 1.82%
Sabby Capital LLC 484,505 1.52%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Biopharmaceuticals
Advertisement
Sector Biopharmaceuticals
1st jan.Capitalization (M$)
CARDIOME PHARMA CORP-63.68%93
BIOGEN INC-5.49%62 611
CSL LIMITED-9.79%32 310
ALEXION PHARMACEUTICAL..-30.76%29 616
BIOMARIN PHARMACEUTICA..-21.08%14 220
GRIFOLS SA-17.50%11 817
CHONGQING ZHIFEI BIOLO..--.--%4 364
3SBIO INC-29.17%2 488
JIANGXI BOYA BIO-PHARM..--.--%2 266
ABCAM PLC19.85%2 040
PROMETIC LIFE SCIENCES..-39.39%942
HUGEL INC--.--%910
ANIKA THERAPEUTICS INC26.15%726
BIOTEST AG-9.63%626
PHARMA MAR SA-0.40%586
ARGOS THERAPEUTICS INC112.12%202
VIVUS, INC.35.29%145
MEDIWOUND LTD-40.87%110
PEREGRINE PHARMACEUTIC..-65.79%97
ALIMERA SCIENCES INC-52.07%75
VERICEL CORP6.59%66
Sector Biopharmaceuticals
Cardiome Pharma Corp : Connections
Cardiome Pharma Corp.
1441 Creekside Drive
6th Floor
Vancouver, BC V6J 4S7

Phone : +1.604.677.6905
Fax : +1.604.677.6915
Web : www.cardiome.com
© 2016 People , Fundamentals and Ownership